Rixa Health Review: The Only Provider That Publishes a Price for Every Dose Level

What Is Rixa Health?

Rixa Health is a functional-medicine telehealth practice rather than a pure GLP-1 storefront. Its catalog spans medical weight loss, women's HRT, testosterone restoration, thyroid health, peptide therapy, custom functional lab work, and — distinctively and controversially — GLP-1s for teens.

What brought it to our attention is its pricing page, which is the most transparent we have encountered anywhere in this market. Rather than a single 'from' figure, Rixa publishes a full dose ladder: five semaglutide levels from $195 to $310 and six tirzepatide levels from $280 to $525, each labelled with its exact weekly milligram dose and supply period.

The accompanying commitment matters just as much: 'The prices below cover everything for 4 weeks, including medication, shipping and any provider interactions you need between refills. We also offer no contracts or long term commitments.' That is an all-in price with unlimited provider contact and no lock-in — a combination almost no competitor offers in writing.

Rixa also names its clinicians publicly with credentials and experience, which is rare. The practice lists a board-certified nurse practitioner and three board-certified D.O. physicians, all described as certified peptide specialists.

Medications Offered & Pricing

Rixa states each price 'includes visit and pass-through cost of medications directly shipped to you separately from Rixa Health by preparing compounding pharmacy.' Note the two five-week supply periods on semaglutide Levels 3 and 4, which slightly change the effective monthly cost. Rixa also lists oral semaglutide, oral tirzepatide and retatrutide among its weight-loss offerings, though those are not individually priced on the pricing page.

Brand-Name or Compounded?

Rixa Health is a compounded provider. Its GLP-1 offerings are compounded semaglutide and compounded tirzepatide, with oral formulations of each also described, and medication is shipped directly by the preparing compounding pharmacy.

As with every compounded provider: compounded semaglutide and tirzepatide are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not generic versions of Ozempic, Wegovy, Mounjaro or Zepbound. Rixa maintains a 'Partner Pharmacies' page, which is more than most competitors offer, though it does not name a single pharmacy on the pricing page itself.

One item on Rixa's weight-loss list deserves particular scrutiny: retatrutide. Retatrutide is an investigational compound that has not been approved by the FDA for any use, and it has not completed the trials that would establish its safety and efficacy profile. Compounded retatrutide sits in a materially different risk category from compounded semaglutide or tirzepatide, whose active molecules at least have approved brand equivalents. If retatrutide is proposed to you, ask the prescriber directly what evidence supports it and understand you would be taking a drug that no regulator has cleared.

The same caution applies to Rixa's 'GLP-1s for Teens' service. GLP-1 prescribing in adolescents is an established but carefully governed area of medicine, and compounded products in that population raise the stakes further. This is a conversation for a pediatric clinician who knows the patient, not something to arrange through an online intake without careful thought.

The Consultation Process

Eligibility

• •Eligibility is determined by Rixa's licensed providers during a consultation — this is a clinician-led practice rather than a pure async questionnaire model.
• •Rixa currently takes clients in 44 states plus the District of Columbia, and lists Alaska, Arkansas, Hawaii, North Dakota and South Dakota as coming soon.
• •Rixa separately offers a 'GLP-1s for Teens' service, indicating it will consider adolescent patients — an area requiring particularly careful clinical judgment.
• •A specific published BMI threshold is not disclosed on the pricing page.
• •Because Rixa is a functional-medicine practice, custom lab work is available and may inform prescribing, though it is priced separately.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Shipping is included in every published price. Rixa advertises 'US Pharmacies • Fast Shipping • 24/7 Access.' Medication ships directly from the preparing compounding pharmacy rather than from Rixa itself. Specific delivery windows and cold-chain handling are not published — worth asking about, since GLP-1s are temperature-sensitive.

• •All provider interactions between refills included in the price
• •No contracts or long-term commitments
• •Free consultations
• •24/7 access advertised
• •Named, credentialled clinicians rather than anonymous prescribers
• •Custom functional lab work available separately
• •Access to broader services — HRT, thyroid, testosterone, peptides — under one practice

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Rixa Health May Be Best For

• •Shoppers who want to know exactly what they will pay at every stage of titration before starting
• •Patients who value unlimited provider contact included in the price rather than billed per visit
• •People who want a named, credentialled clinician rather than an anonymous async reviewer
• •Patients who dislike contracts and want to stop between refills without penalty
• •Anyone wanting GLP-1 care alongside HRT, thyroid or functional lab work in one practice
• •Patients paying with HSA or FSA funds

Limitations

• •The transparency cuts both ways. Rixa shows you the dose ladder, and what it shows is that maintenance-dose tirzepatide costs $525 per four weeks — roughly triple what several competitors charge. The honesty is admirable; the price is not competitive at the top end.
• •Retatrutide is the most significant concern in this review. It is an investigational compound with no FDA approval for any indication, and compounding it for consumer use places it outside the framework that governs even the compounded semaglutide market. Treat any offer of it with real caution.
• •The teen GLP-1 offering warrants the same care. Adolescent obesity pharmacotherapy is legitimate medicine, but it belongs with a clinician who knows the patient and family, and compounded products add risk that brand-name products do not carry.
• •No published refund policy is a gap, though the absence of contracts reduces how much it can cost you.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Rixa Health publishes something no other provider we have reviewed will: the actual cost of getting to a therapeutic dose. Every provider knows that GLP-1 therapy escalates and that the advertised starting price is not what most patients end up paying. Rixa simply prints the whole ladder, attaches the milligram dose to each rung, and tells you that the figure covers medication, shipping and as much provider contact as you need. That is the single most useful pricing page in this market.

The clinician transparency is equally strong. Named providers with real credentials and stated years of experience, unrushed consultations, and unlimited included provider contact make this feel like a medical practice rather than a checkout funnel — which is what it is.

Two things temper our enthusiasm. First, price: at maintenance doses Rixa is expensive, with 15 mg tirzepatide at $525 per four weeks against competitors charging a fraction of that. Second, and more seriously, the catalog reaches into territory we would not follow — compounded retatrutide has no FDA approval for any indication, and marketing GLP-1s for teens through a telehealth practice invites decisions that belong with a clinician who knows the family. Those offerings do not make Rixa a bad provider for adults seeking semaglutide or tirzepatide, where it is genuinely excellent on transparency. They do mean you should be deliberate about what you say yes to.